LSL Pharma Group (TSXV:LSL) LT-Debt-to-Total-Asset : 0.25 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. LSL Pharma Group's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.25.

LSL Pharma Group's long-term debt to total assets ratio declined from Mar. 2023 (0.28) to Mar. 2024 (0.25). It may suggest that LSL Pharma Group is progressively becoming less dependent on debt to grow their business.

LSL Pharma Group LT-Debt-to-Total-Asset Historical Data

The historical data trend for LSL Pharma Group's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group LT-Debt-to-Total-Asset Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

0.19

0.37

0.38

0.23

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial								0.28	0.29	0.19	0.23	0.25

LSL Pharma Group LT-Debt-to-Total-Asset Calculation

LSL Pharma Group's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	7.171	/	30.9
	=	0.23

LSL Pharma Group's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	8.228	/	32.97
	=	0.25

LSL Pharma Group (TSXV:LSL) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

LSL Pharma Group LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group (TSXV:LSL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5

Website

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines